{"url":"https://lda.senate.gov/api/v1/filings/dc0fd143-93a8-408e-ae2b-e7ec3e326a76/","filing_uuid":"dc0fd143-93a8-408e-ae2b-e7ec3e326a76","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2013,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/dc0fd143-93a8-408e-ae2b-e7ec3e326a76/print/","filing_document_content_type":"text/html","income":"45000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kelly Childress, Partner","dt_posted":"2013-07-09T09:17:51.717000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 7th Street, NW","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400646949,"url":"https://lda.senate.gov/api/v1/registrants/400646949/","house_registrant_id":null,"name":"EAST END GROUP, LLC","description":"Consulting and government affairs.","address_1":"3 W. Irving St.","address_2":"Suite 200","address_3":null,"address_4":null,"city":"Chevy Chase","state":"MD","state_display":"Maryland","zip":"20815","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KELLY CHILDRESS LANGE","contact_telephone":"+1 202-688-1814","dt_updated":"2026-07-29T12:19:27.077010-04:00"},"client":{"id":193822,"url":"https://lda.senate.gov/api/v1/clients/193822/","client_id":164,"name":"ACHAOGEN, INC","general_description":"Biotechnology pharmaceutical product discovery and development.","client_government_entity":false,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-03-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure development and procurement, including H.R. 2405, the Pandemic and All-Hazards Preparedness Act Reauthorization; and the Food and Drugs Administration legislative and regulatory issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":52414,"prefix":null,"prefix_display":null,"first_name":"BARRETT","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":53306,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"PAUL","last_name":"WOODY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142657,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"THOMSON","last_name":"MOHLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150526,"prefix":"mrs","prefix_display":"MRS.","first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CHILDRESS LANGE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}